510(k) · Cleared
ClearedPenumbra Coil 400, Ruby Coil System, POD System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Penumbra, Inc. · HCG Device, Neurovascular Embolization
Cleared on Apr 17, 2018 as substantially equivalent to K120330 (Penumbra, Inc., 2012) after a 146-day review. Its family tree reaches back 10 generations to 1995. 1 later device descends from it.
- Decided
- Apr 17, 2018
- Review
- 146 days
- Class
- Class II
- Product code
- HCG
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 10 generations to K951256 (1995). 36 ancestors in all, the oldest K860840 (1986). 1 later device descends from it, 1 citing it directly.
- Root · 10 generations backK951256 Detachable Platinum Coil (Guglielmi Detachable Coil, GDC)Target Therapeutics · 1995
- 6 generations between
- 3 generations backK093142 Target Detachable Coils and Inzone Detachment SystemBoston Scientific Corp · 2010
- 2 generations backK103305 Penumbra Embolization Coil SystemPenumbra, Inc. · 2011 · Recalled
- 1 generation backK120330 Penumbra Coil System/Penumbra Coil 400Penumbra, Inc. · 2012
- This deviceK173614 Penumbra Coil 400, Ruby Coil System, POD SystemPenumbra, Inc. · 2018
- Descendant · cites it directly · 0 of its ownK250079 Ruby XL SystemPenumbra, Inc. · 2025
Show all 10 generations
- Root · 10 generations backK951256 Detachable Platinum Coil (Guglielmi Detachable Coil, GDC)Target Therapeutics · 1995
- 9 generations backK960705 Guglielmi Detachable CoilTarget Therapeutics · 1996
- 8 generations backK962503 Guglielmi Detachable CoilTarget Therapeutics · 1996
- 7 generations backK971395 Guglielmi Detachable Coil (GDC), Fibered Platinum Coil, .035 Type…Target Therapeutics · 1997
- 6 generations backK991139 Guglielmi Detachable (GDC)Boston Scientific, Target · 1999
- 5 generations backK042539 GDC-10 360 Degree Coil SR; GDC-10 360 Degree Soft Coil SR; GDC-18…Boston Scientific Corp · 2004 · Recalled
- 4 generations backK050700 Matrix Stretch Resistant (SR) CoilsBoston Scientific Corp · 2005 · Recalled
- 3 generations backK093142 Target Detachable Coils and Inzone Detachment SystemBoston Scientific Corp · 2010
- 2 generations backK103305 Penumbra Embolization Coil SystemPenumbra, Inc. · 2011 · Recalled
- 1 generation backK120330 Penumbra Coil System/Penumbra Coil 400Penumbra, Inc. · 2012
- This deviceK173614 Penumbra Coil 400, Ruby Coil System, POD SystemPenumbra, Inc. · 2018
Most influential descendants
Showing 1 of 1 · See all- K250079Ruby XL SystemPenumbra, Inc. · 2025 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −10 | K951256 | Detachable Platinum Coil (Guglielmi Detachable Coil, GDC) | Target Therapeutics | 1995 | — |
| −9 | K960705 | Guglielmi Detachable Coil | Target Therapeutics | 1996 | — |
| −8 | K962503 | Guglielmi Detachable Coil | Target Therapeutics | 1996 | — |
| −7 | K971395 | Guglielmi Detachable Coil (GDC), Fibered Platinum Coil, .035 Type, Berenstein… | Target Therapeutics | 1997 | — |
| −6 | K991139 | Guglielmi Detachable (GDC) | Boston Scientific, Target | 1999 | — |
| −5 | K042539 | GDC-10 360 Degree Coil SR; GDC-10 360 Degree Soft Coil SR; GDC-18 360 Degree… | Boston Scientific Corp | 2004 | 2 |
| −4 | K050700 | Matrix Stretch Resistant (SR) Coils | Boston Scientific Corp | 2005 | 1 |
| −3 | K093142 | Target Detachable Coils and Inzone Detachment System | Boston Scientific Corp | 2010 | — |
| −2 | K103305 | Penumbra Embolization Coil System | Penumbra, Inc. | 2011 | 1 |
| −1 | K120330 | Penumbra Coil System/Penumbra Coil 400 | Penumbra, Inc. | 2012 | — |
| 0 (this device) | K173614 | Penumbra Coil 400, Ruby Coil System, POD System | Penumbra, Inc. | 2018 | — |
| +1 | K250079 | Ruby XL System | Penumbra, Inc. | 2025 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1986 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 5 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 2000 | 2 | 0 |
| 2002 | 2 | 0 |
| 2003 | 3 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2025 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in HCG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new HCG device
- #1 K252700 Optima Coil System (Optima Packing Coil System)score 20.6 · 26 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K250079 | Ruby XL System | 2025 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 23 years and passes through 4 companies; a new generation was cleared every 1.2 years on median.
- 8 of the 36 ancestors have a recall of any class.
- Of its descendants, K250079 (Penumbra, Inc., 2025) has gone furthest, with 0 descendants of its own.
- 2 other devices also cite its predicate K120330.
How does its category compare?
All HCG devicesHCG Device, Neurovascular Embolization: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.
FDA decisions per year · HCG
3in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · HCG
107in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · HCG
1in 2025
Class I (1 since 2007) Class II/III not classified
Adverse event reports per year · HCG
537in 2025
MAUDE reports naming product code HCG, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 8 | 50 | 1 | 326 |
| 2008 | 9 | 71 | 3 | 730 |
| 2009 | 7 | 48 | 0 | 821 |
| 2010 | 8 | 72 | 2 | 851 |
| 2011 | 9 | 78 | 1 | 894 |
| 2012 | 7 | 30 | 0 | 1,146 |
| 2013 | 7 | 67 | 2 | 1,103 |
| 2014 | 5 | 66 | 4 | 1,729 |
| 2015 | 5 | 60 | 0 | 1,598 |
| 2016 | 7 | 37 | 0 | 1,991 |
| 2017 | 5 | 97 | 0 | 2,494 |
| 2018 | 4 | 173 | 0 | 2,058 |
| 2019 | 1 | — | 0 | 1,763 |
| 2020 | 2 | — | 0 | 1,754 |
| 2021 | 5 | 103 | 0 | 2,268 |
| 2022 | 3 | 114 | 2 | 663 |
| 2023 | 2 | — | 0 | 568 |
| 2024 | 4 | 49 | 1 | 552 |
| 2025 | 3 | 107 | 1 (1) | 537 |
| 2026 | 4 | 30 | 1 | — |
What is it indicated for?
Penumbra Coil 400 The Penumbra Coil 400 is indicated for the embolization of: • Intracranial aneurysms. • Other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. • Arterial and venous embolizations in the peripheral vasculature. Ruby Coil System Ruby Coil System is indicated for arterial and venous embolizations in the peripheral vasculature. POD System (For POD Coils with nominal sizes ≤ 6 mm) The POD System is…
Read the full statement (121 words)
Penumbra Coil 400
The Penumbra Coil 400 is indicated for the embolization of:
• Intracranial aneurysms.
• Other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae.
• Arterial and venous embolizations in the peripheral vasculature.
Ruby Coil System
Ruby Coil System is indicated for arterial and venous embolizations in the peripheral vasculature.
POD System (For POD Coils with nominal sizes ≤ 6 mm)
The POD System is indicated for the embolization of:
• Intracranial aneurysms.
• Other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae.
• Arterial and venous embolizations in the peripheral vasculature.
POD System (For POD Coils with nominal sizes > 6 mm)
The POD System is indicated for arterial and venous embolizations in the peripheral vasculature.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K173614 · printed Nov 6, 2026
Cite this page
510(k) Report. “K173614: Penumbra Coil 400, Ruby Coil System, POD System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K173614
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026